Learn More
Medchemexpress LLC Tipiracil | 183204-74-2 | 99.98% | C9H11ClN4O2 | 200 MG

Supplier: Medchemexpress LLC HYA0063A200MG
Tipiracil is a thymidine phosphorylase (TPase) inhibitor intended for research use only. It increases trifluridine exposure by inhibiting its metabolism by thymidine phosphorylase. The combination of Trifluridine and Tipiracil is a new oral treatment for metastatic colorectal cancer.
- Thymidine phosphorylase (TPase) inhibitor
- Increases trifluridine exposure
- Prevents degradation of FTD
- New oral treatment for metastatic colorectal cancer
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.